A private-label starch premix project starts long before the first batch, and most of what has to exist at day one is on your side of the table, not the supplier’s. Five deliverables decide whether a contract manufacturer can run your brand legally: a frozen formula and specification you own, a label dossier built on the rule that the name printed on the bag carries the regulatory relationship, a packaging specification, a document set the supplier ships against, and a written sample release. The question every buyer asks — if the formula changes, who pays to reprint the bags — has no legal answer; it is purely contractual, and the legal default is narrower than it looks. This guide separates the two for you.
Whose Name on the Bag Decides Which Question?
Two things people merge into one are actually separate: who the regulator looks at, and who pays when artwork changes.
Regulatory responsibility follows the name on the package. In the United States, 21 CFR 101.5 requires the label of a packaged food to state the name and place of business of the manufacturer, packer or distributor. In the European Union, Regulation (EU) No 1169/2011 makes the operator under whose name or business name the food is marketed — or, if that operator is not established in the EU, the importer into the Union market — the business responsible for the food information. Neither rule says the named party pays for reprints. Those rules say whose compliance file the product belongs to.
Cost responsibility is a contract question. If a supplier changes a formulation without your written approval and the ingredient declaration shifts, then under a contract that requires your approval for changes, the reprint is their breach and their cost. If you ask for the change, it is your project and your line item. If you agree together to improve the blend, the contract should already say who carries print and bag-stock write-offs. If your contract does not say, that silence is the most expensive sentence in the document.
What Does “Manufactured for” Actually Buy You?
When your company commissions production but does not run the plant, 101.5(c) requires the name on the label to be qualified by a phrase revealing the real relationship — “Manufactured for …”, “Distributed by …”, or wording that states the facts. This is not a courtesy line. It tells inspectors, retailers and customers which business stands behind the product and where the records live.
Buyers read this as a liability transfer and conclude the contract is settled. It is not. The qualifier establishes the relationship for the label; the commercial terms — who owns the formula, who pays for artwork revisions, who absorbs bag write-offs — appear nowhere in either rule above. They belong in your manufacturing agreement. Get both documents right and the reprint argument disappears, because the change-control clause, not a federal statute, is what assigns cost.
What Five Things Must Exist on Your Side Before the First Batch?
A premix manufacturer cannot start a compliant private-label run from a verbal brief. These five deliverables are yours to produce or sign before any batch is committed.
- Frozen formula and functional specification. The ingredient list in descending order, target viscosity behavior, dosage, and the processing window the blend is designed for — the same custom blending specification logic applies whether you bring the formula or commission it. This document is the baseline every later change is measured against — including whether a later change is a change at all.
- Label dossier with the naming rule already applied. Your legal entity name and address, the correct statement of the relationship (“Manufactured for …”), ingredient declarations, allergen and nutritional panels for your market. Do not let the supplier “handle the label” without a named owner.
- Packaging specification. Bag format, barrier structure, net weights, batch-coding zone, and the artwork version under which every reprint is compared. The version number is what turns a reprint dispute into a yes-or-no check.
- Document set that ships with every batch. Per-lot COA, the TDS matched to the frozen formula, and any religious or market certificates your buyers demand. Define acceptance criteria before the first delivery so a missing document has a defined consequence.
- Written release of the production sample. A signed document stating that the sample you approved, with its retained reference, is the standard the first batch is judged against. Verbal “it looks fine” is not a release; it is an argument waiting to happen.
When the Formula Shifts, Who Eats the Reprint Cost?
Split them the way a well-drafted contract does, and the conflicting answers you may have seen online collapse into one decision tree.
You requested the change. You own the artwork update, the print cost and any obsolete bag stock. A supplier asked to improve a blend mid-contract without re-quoting is a red flag, not a favor.
The supplier changed it for their own reason — raw material availability, a process fix — without your written approval. Under a competent change-control clause this is their breach: revised specification, new label review and the reprint all sit on their side before the next shipment moves. Your approval is not a formality you can be bypassed on.
You agree the change together — a cost reduction, a supply fix, a better blend. Nothing was breached, but bags and print still change. The contract should have said in advance who carries the reprint and the obsolete stock; if it did not, you are negotiating after the fact with the supplier’s calendar against you.
A regulator or customer forced the change. Nobody caused it; the contract you signed before launch decides who carries it. If your agreement is silent, you are negotiating with the supplier’s calendar and your retail deadline as your only leverage.
The common thread: the legal rules decide whose name and whose records; the contract decides whose money. Mixing them up either makes you pay for someone else’s breach or leads you to expect a federal statute to reimburse your bags. It will not.
How Do You Protect a Formula You Do Not Manufacture?
The premise of a private-label program is that the supplier runs production but the product identity is yours. Three mechanisms make that hold, and none of them is a clause in an email.
- Written change control with a decision tree. Any change to the base starch, any ingredient substitution, any adjustment to cross-link level, carrier or allergen-bearing component triggers a written notice, your approval, and a defined reprint rule before anything ships.
- Documented exclusivity, if you want it. A formula you commissioned can be licensed to the manufacturer for your production only, with a term and a survival clause. Silence means the plant may treat your blend as one more line in its catalogue.
- The right confidentiality instrument for the jurisdiction. For production in China, the working document is a bilingual non-disclosure, non-use, non-circumvention agreement: it bars the supplier from using your formula for anyone else’s orders and from taking the product to your customers directly. A one-page generic NDA gives you a signature, not enforceability.
On the supplier side, the reciprocal protection matters as much: retained reference samples from the approved batch and a batch-coded archive let you prove which version a disputed lot actually came from. A formula dispute without retained samples is a shouting match with a print invoice attached.
What Is the Smallest First Run That Still Makes Sense?
Forget the “minimum viable volume” numbers you will find online — they come from supplement and cosmetics packaging economics, not from bulk food-ingredient premixes, and applying them to starch is guessing. The honest floor is defined by three real constraints: the packaging line’s practical print run for your bag format, the trial pathway your supplier actually operates, and how much material your own qualification needs.
A sensible sequence uses the trial steps a manufacturer can document — laboratory sample first, then a trial batch, then a full order, the pathway mapped in our MOQ reality guide — instead of committing a year of bag stock to an unproven formula. Your qualification should consume a real production run, not a demo bag: if the first sale-ready batch cannot pass your line and label checks, the volume was wasted whatever its size. Start where the process lets you stop cleanly.
FAQ
Can we sell a premix under our brand without owning a food factory?
Yes — that is what private label means. Your name on the bag plus the relationship wording makes you the identified food business for the market’s labeling rules; the factory’s role appears in the contract and audit record, not on the front panel.
Who owns the formula the supplier developed for us?
The contract decides, and nothing else does. A development fee paid by you should come with written ownership or at minimum an exclusive-use clause naming the supplier’s own use limits. If ownership is unstated, assume the plant treats it as their background know-how.
Does the “Manufactured for” line make the supplier legally responsible?
No. It states the relationship truthfully so regulators and customers can see who stands behind the product — typically you, the brand owner. It transfers no duties to the factory.
The supplier wants to change the base starch without asking us. Is that legal?
Food law does not police it; your change-control clause does. Without written approval you may face a lot that no longer matches the declared specification you filed. That is why the clause names the trigger items before anyone needs the argument.
Should a private-label audit cover the whole factory?
It should cover the line, the product family and the controls that touch your blend — allergen segregation, batch coding, retained samples, change records. “The whole factory” is not the right unit; the right unit is anything that can reach your bag.
If you want to put these five deliverables on a real production plan, tell GFMStech the market your label serves and the blend you have in mind — our OEM and private-label services start from your frozen formula and your retained sample, not from our catalogue.
